SEC Form 4 · accession 0001225208-15-020654
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Michael Fitzgerald
Officer — EVP & President, CRM
Period of report
Nov 9, 2015
Accepted (ET)
Nov 10, 2015 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 9, 2015 | S | 26,220 | $18.5843 | D | 103,925 | D | |
| Common StockF3 | holding | — | — | — | 68,790 | I | By 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average sale price. These shares were sold in multiple transactions at $18.57 and $18.6101. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F3Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.